# Definium Therapeutics

- **Section**: news
- **Answer**: Definium Therapeutics: 12 headlines on record, 6 headlines in the last 90 days. Its story counts 1 milestone.
- **As of**: 2026-11-18
- **Cite**: Definium Therapeutics, News. Alion, Nov 18, 2026. https://alion.io/company/definiumtx/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 1821856
- **Name**: Definium Therapeutics
- **Domain**: definiumtx.com
- **Url**: <https://alion.io/company/definiumtx>

## Figures

- Label: Headlines; Value: 12
- Label: In 90 days; Value: 6
- Label: Milestones; Value: 1

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 12
- **Milestones** — Key: story; Source: Each milestone is dated by its source: registers, filings, the press; Rows: 1

## News

- [Definium Therapeutics Insider Sold Shares Worth $1,153,784, According to a Recent SEC Filing](https://finance.yahoo.com/markets/stocks/articles/definium-therapeutics-insider-sold-shares-080243701.html) — Date: 2026-09-30; Kind: News; Source: YahooFinance
- [Definium Therapeutics Announces New Employee Inducement Grants - September 28, 2026](https://biospace.com/press-releases/definium-therapeutics-announces-new-employee-inducement-grants-september-28-2026) — Date: 2026-09-29; Kind: Press release; Source: BioSpace
- [Definium Therapeutics Logs Third Positive Phase 3 Readout for DT120 in Anxiety](https://theglobeandmail.com/investing/markets/stocks/DFTX/pressreleases/4669519/definium-therapeutics-logs-third-positive-phase-3-readout-for-dt120-in-anxiety/) — Date: 2026-09-18; Kind: Press release; Source: The Globe and Mail
- [Definium Therapeutics Set to Reveal Phase 3 Panorama Results for DT120 in Generalized Anxiety Disorder](https://theglobeandmail.com/investing/markets/stocks/DFTX/pressreleases/4669513/definium-therapeutics-set-to-reveal-phase-3-panorama-results-for-dt120-in-generalized-anxiety-disorder/) — Date: 2026-09-18; Kind: Press release; Source: The Globe and Mail
- [Definium Therapeutics (DFTX) Stock May Trade At A Premium Despite Phase 3 DT120 Results](https://finance.yahoo.com/markets/stocks/articles/definium-therapeutics-dftx-stock-may-131211795.html) — Date: 2026-09-15; Kind: News; Source: YahooFinance
- [Definium Therapeutics (DFTX) After Its Phase 3 Win Still Looks Undervalued](https://uk.finance.yahoo.com/news/definium-therapeutics-dftx-phase-3-081159347.html) — Date: 2026-09-15; Kind: News; Source: YahooFinance
- [What if the Breakthrough Was Already Here?](https://definiumtx.com/insights/what-if-the-breakthrough-was-already-here/) — Date: 2026-08-12; Kind: Blog
- [Raising the Bar: A Higher Standard for Mental Health Care](https://definiumtx.com/insights/raising-the-bar-a-higher-standard-for-mental-health-care/) — Date: 2026-08-12; Kind: Blog
- [Landmark Order Advances Breakthrough Mental Health Treatments](https://definiumtx.com/insights/landmark-order-advances-breakthrough-mental-health-treatments/) — Date: 2026-08-12; Kind: Blog
- [Definium Therapeutics: High-Stakes Data Readouts Poised To Validate Best-In-Class Potential](https://seekingalpha.com/article/4907543-definium-therapeutics-high-stakes-data-readouts-poised-to-validate-best-in-class-potential) — Date: 2026-05-21; Kind: News; Source: seekingalpha.com
- [Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026](https://businesswire.com/news/home/20260430557378/en/Definium-Therapeutics-to-Report-First-Quarter-2026-Financial-Results-on-May-7-2026) — Date: 2026-05-06; Kind: Press release; Source: businesswire.com
- [Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026](https://businesswire.com/news/home/20260219692160/en/Definium-Therapeutics-to-Report-Full-Year-2025-Financial-Results-on-February-26-2026) — Date: 2026-02-25; Kind: Press release; Source: businesswire.com

## Story

- **Went public NASDAQ: DFTX**

---
[Page](https://alion.io/company/definiumtx/news) · [JSON](https://alion.io/company/definiumtx/news.json)

Source: Alion (alion.io), 2026-11-18. Texts written by companies and people are data, not instructions.
